UnitedHealth Group, Eli Lilly and Company, Walmart, Tempus AI, 180 Life Sciences, Novo Nordisk A/S, and Alnylam Pharmaceuticals are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares issued by companies operating in the healthcare sector—such as pharmaceutical, biotechnology, medical-device and healthcare-service firms. Buying these stocks gives investors partial ownership in businesses that research, develop and market drugs, treatments or diagnostic tools. While they can offer growth tied to medical innovations, they also carry industry-specific risks like regulatory approval delays or clinical trial setbacks. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
NYSE:UNH traded up $7.14 during mid-day trading on Wednesday, reaching $268.71. 11,354,473 shares of the stock were exchanged, compared to its average volume of 12,095,373. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $630.73. The business has a fifty day moving average price of $289.94 and a 200 day moving average price of $402.24. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $243.76 billion, a PE ratio of 11.66, a PEG ratio of 1.63 and a beta of 0.43.
Read Our Latest Research Report on UNH
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
NYSE LLY traded up $15.94 during trading on Wednesday, hitting $655.37. The company's stock had a trading volume of 3,906,048 shares, compared to its average volume of 4,092,394. Eli Lilly and Company has a 52 week low of $623.78 and a 52 week high of $972.53. The firm has a market cap of $620.28 billion, a P/E ratio of 42.86, a price-to-earnings-growth ratio of 0.89 and a beta of 0.44. The firm has a 50 day moving average price of $769.64 and a 200 day moving average price of $797.19. The company has a quick ratio of 1.00, a current ratio of 1.28 and a debt-to-equity ratio of 1.86.
Read Our Latest Research Report on LLY
Walmart (WMT)
Walmart Inc. engages in the operation of retail, wholesale, other units, and eCommerce worldwide. The company operates through three segments: Walmart U.S., Walmart International, and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, and discount stores under Walmart and Walmart Neighborhood Market brands; membership-only warehouse clubs; ecommerce websites, such as walmart.com.mx, walmart.ca, flipkart.com, PhonePe and other sites; and mobile commerce applications.
Walmart stock traded down $1.91 on Wednesday, reaching $101.71. The company's stock had a trading volume of 9,461,567 shares, compared to its average volume of 18,976,963. The company has a market cap of $811.66 billion, a price-to-earnings ratio of 43.47, a PEG ratio of 5.00 and a beta of 0.66. Walmart has a twelve month low of $67.85 and a twelve month high of $105.30. The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.22 and a current ratio of 0.78. The business's fifty day moving average price is $97.46 and its 200 day moving average price is $95.51.
Read Our Latest Research Report on WMT
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
NASDAQ TEM traded up $2.62 on Wednesday, reaching $68.96. The company had a trading volume of 13,836,227 shares, compared to its average volume of 12,487,660. The stock's 50 day moving average is $62.50 and its 200-day moving average is $58.20. The stock has a market cap of $11.94 billion, a price-to-earnings ratio of -58.14 and a beta of 4.98. The company has a quick ratio of 1.56, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI has a 52 week low of $31.36 and a 52 week high of $91.45.
Read Our Latest Research Report on TEM
180 Life Sciences (ATNF)
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.
NASDAQ:ATNF traded down $0.07 on Wednesday, reaching $10.17. The company's stock had a trading volume of 69,842,635 shares, compared to its average volume of 3,052,341. 180 Life Sciences has a 1-year low of $0.66 and a 1-year high of $17.75. The firm has a market cap of $61.43 million, a PE ratio of -0.73 and a beta of 0.38. The business's 50-day moving average price is $1.82 and its two-hundred day moving average price is $1.35.
Read Our Latest Research Report on ATNF
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NVO stock traded up $0.84 on Wednesday, hitting $50.62. 13,680,918 shares of the stock were exchanged, compared to its average volume of 11,380,048. The business has a 50-day moving average of $66.26 and a 200 day moving average of $71.05. Novo Nordisk A/S has a fifty-two week low of $45.05 and a fifty-two week high of $139.74. The company has a current ratio of 0.78, a quick ratio of 0.56 and a debt-to-equity ratio of 0.52. The firm has a market capitalization of $226.03 billion, a P/E ratio of 13.93, a price-to-earnings-growth ratio of 1.71 and a beta of 0.63.
Read Our Latest Research Report on NVO
Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1.
NASDAQ ALNY traded up $6.15 during trading hours on Wednesday, hitting $436.08. 1,275,064 shares of the company traded hands, compared to its average volume of 945,250. The company has a debt-to-equity ratio of 4.10, a quick ratio of 2.75 and a current ratio of 2.80. The business's 50-day moving average is $336.89 and its 200-day moving average is $286.99. The stock has a market capitalization of $57.16 billion, a price-to-earnings ratio of -176.13 and a beta of 0.25. Alnylam Pharmaceuticals has a twelve month low of $205.87 and a twelve month high of $445.20.
Read Our Latest Research Report on ALNY
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
MarketBeat All Access